Peculiarities of the carbohydrate metabolism in patients with chronic obstructive pulmonary disease and concomitant chronic pancreatitis

Main Article Content

O.O. Ursul


Background. Chronic obstructive pulmonary disease is a leading cause of morbidity and mortality in the world. We can see a combination of chronic obstructive pulmonary disease with disorders of the digestive system, such as chronic pancreatitis, in clinical practice. The functional status of the pancreas plays a direct role in the development of the main components of the metabolic syndrome (hyperinsulinemia, insulin resistance with impaired glucose tolerance). Materials and methods. We have examined 90 patients with chronic obstructive pulmonary disease and chronic pancreatitis, and studied of carbohydrate metabolism, lipid peroxidation and the content of final metabolites of nitric oxide (nitrites/nitrates). Results. The study found an increase in the degree of insulin resistance and the development of oxidative stress. Comprehensive treatment of patients with chronic obstructive pulmonary disease and chronic pancreatitis, which included the administration of basic therapy and reduced glutathione, led to a decrease of the insulin resistance and the restoration of serum reduced glutathione. Conclusions. Decrease in the serum reduced glutathione and the increase of serum level of final metabolites of nitric oxide is accompanied by the increase of degree of insulin resistance.

Article Details

How to Cite
Ursul, O. “Peculiarities of the Carbohydrate Metabolism in Patients With Chronic Obstructive Pulmonary Disease and concomitant Chronic Pancreatitis”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 1, Feb. 2017, pp. 66-71, doi:10.22141/2224-0721.13.1.2017.96760.
Original Researches


Beljalov FI. The problem of comorbidity in the diseases of the internal organs. Vestnik sovremennoj klinicheskoj mediciny. 2010;3(2):44-47 (in Russian).

Gubergric NB, Jaroshenko LA. Dynamics of the exocrine pancreatic function in patients with chronic pancreatitis, combined with chronic bronchitis under the influence of magnesium therapy. Gastroenterologija. 2013;3(49):74-77 (in Russian).

Mostovij JM, Rasputіna LV, Dovgan’ AO, Ovcharuk MV. The problem of comorbid states in the national agreement for the diagnosis and treatment of chronic obstructive pulmonary disease from the position of personal experience. Discussion order №555. Bukovins’kij medichnij vіsnik. 2014;3(71):221-226 (in Ukrainian).

Tan B, Li X, Yin Y et al. The regulatory role of the L-arginine in reducing the volume of the white adipose tissue. Front Biosci. 2012 Jun 1;17:2237-2246. PMCID: PMC3422877.

Unificated clinical protocols of the primary, secondary (specialized), the third (highly specialized) care and rehabilitation. Chronic obstructive pulmonary disease. Nakaz MOZ Ukraїni vіd 27.06.2013 № 555 (in Ukrainian).

Unificated clinical protocols of the primary and the secondary (specialized) care and rehabilitation. Chronic pancreatitis. Nakaz MOZ Ukraїni vіd 10.09.2014 № 638 (in Ukrainian).

Ferfec’ka KV, Fedіv OІ. The role of the metabolic syndrome in the development of chronic pancreatitis (literature review). Bukovins’kij medichnij vіsnik. 2013;2(66):174-177 (in Ukrainian).

Stupnic’ka GJ., Fedіv OІ, Prituljak OV, Juhimchuk VV. Chronic obstructive pulmonary disease has two sides of the same medal. Ukraїns’kij terapevtichnij zhurnal. 2013;4:85-92 (in Ukrainian).

Feshhenko JІ, Jashina LO, Dzjublik OJ et al. Chronic obstructive pulmonary disease: etiology, pathogenesis, classification, diagnosis, therapy (project of the national agreement). Ukraїns'kij pul’monologіchnij zhurnal. 2013;3:7-12 (in Ukrainian).

Bansal S, Caroli R, Goel N, Vijayan VK. Chronic obstructive pulmonary disease as a risk factor for insulin resistance. Сhest. 2010;138(4). doi: 10.1378/chest.10235.

Drews G, Krippeit-Drews P, Dufer M. Oxidative stress and beta-cell dysfunction. Pflugers Archiv-European Journal of Physiology. 2010;460(4):703-718. doi: 10.1007/s00424-010-0862-9.

Shanik MH, Xu Y, Skrha J, Dankner R, Zink Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care. 2008;31(2):262-8. doi: 10.2337/dc08-s264.

Koul PA. Chronic obstructive pulmonary disease: Indian guidelines and the road ahead. Lung Indian. 2013;30(3):175-177. doi: 10.4103/0970-2113.116233.

Mirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweat symphony. Cardiovascular Diabetology. 2012;11(132):46-81. doi: 10.1186/1475-2840-11-132.

Neibisz-Cieslak AB, Karnafel W. Insulin sensitivity in chronic pancreatitis and features of insulin resistance syndrome. Pol Arch Med Wewn. 2010;120(7-8):255-63. PMID: 20693955.

Brindicci С, Kharitonov SA, Ito M et al. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181:21-30. doi: 10.1164/rccm.200904-0493OC.

Pawlak J, Derlacz RA. The mechanism of insulin resistance in peripheral tissues. Postepy Biochem. 2011;57(2):200-6. PMID: 21913421.

Rogliana P, Luca G, Lauro D. Chronic obstructive pulmonary disease and diabetes. COPD Research and Practice. 2015;1(3):1-9. doi: 10.1186/s40749-015-0005-y.

Tan B, Li X, Wu Z. Regulatory roles for L-arginine in reducing white adipose tissue. Frontiers in bioscience: a journal and virtual library. 2012;1(17):2237-2246. PMCID: PMC 3422877.

Wedin WK, Diaz-Gimenez L, Convit AJ. Prediction of insulin resistance with anthropometric measures: lessons from a large adolescent population. Diabetes Metab Syndr Obes. 2012;5:219-225. doi: 10.2147/DMSO.S33478.

Word Health Organization. Burden of COPD. Available from: